SST2 and SST5 are the most abundantly expressed SSTs in the pituitary, where they mediate octreotide and pasireotide inhibitory effects on hormone secretion and cell proliferation, representing the main pharmacological targets for GH-secreting pituitary tumors in acromegaly (22). Here, SSTR2 is linked to pituitary tumor.